Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Bioinspired wearable polymer microneedle patches: pioneering diabetic wound therapy for the horizon

Zhang S., Wei M., Luan C., Gao B.

Narrative Review on Diabetic Foot, published in RSC Adv (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
RSC Adv (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40927479
PMCID
PMC12415957
DOI
10.1039/d5ra02557e
Citations
1

Abstract (original English)

Diabetic wounds present persistent challenges due to impaired healing, recurrent infection, oxidative stress, and dysregulated glucose metabolism. Bioinspired polymeric microneedle (MN) patches have emerged as multifunctional platforms capable of penetrating the stratum corneum to deliver therapeutics directly into the dermis, enabling glucose regulation, antimicrobial action, reactive oxygen species (ROS) modulation, and proangiogenic stimulation. Recent experimental evidence has demonstrated that the integration of glucose oxidase-loaded porous metal-organic frameworks, photothermal nanomaterials, and antioxidant hydrogels within dissolvable MNs achieves synergistic bactericidal effects, accelerates collagen deposition, and enhances neovascularization in diabetic wound models. Stimuli-responsive designs facilitate precise and sustained drug release while reducing off-target effects. Structural innovations, including hollow, multilayer, and bioinspired morphologies, improve mechanical compliance, drug loading, and patient comfort. Despite promising in vivo healing outcomes and improved microenvironment regulation, large-scale manufacturing, long-term stability, and clinical translation remain key challenges. This review highlights advances in MN materials, structures, and mechanisms, providing insights for the development of next-generation intelligent wound therapies.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research